Introduction
Pim-1 was initially identified to be a frequent proviral insertion site in Moloney murine leukemia virus-induced T-cell lymphoma (Cuypers et al., 1984) . It was later identified by us to be a highly conserved Ser/Thr protein kinase (Hoover et al., 1991) . Pim-1 belongs to the Pim kinase family that also includes Pim-2 and Pim-3. There is more than 53% identity in the amino-acid level among the three family members with each having a somewhat different pattern of tissue distribution (Allen et al., 1997) . Because these kinases phosphorylate some of the same substrates, there appears to be a certain level of redundancy in their function. Mice with a deficiency for all Pim kinases display a significant reduction in body size and impaired growth factor signaling in hematopoietic cells, suggesting that physiologically the Pim kinases are important in growth factor signaling (Mikkers et al., 2004) . Deregulated Pim kinase expression was initially reported in a variety of myeloid and lymphoblastic leukemias (Amson et al., 1989) , however, recently, it has also been observed to be highly expressed in some solid tumors such as prostate cancer and pancreatic cancer (Dhanasekaran et al., 2001; Li et al., 2006) . The oncogenicity of Pim-1 kinase was substantiated by the generation of transgenic mice in which Pim-1 was expressed specifically in lymphoid tissue; these mice develop T-cell lymphoma with a 5-10% incidence before 7 months of age (Moroy et al., 1991) . Because Pim-1 induces tumors at a relatively low incidence and with a long latency, it has been classified as a weak oncogene. However, a very strong synergism with regards to tumorigenicity occurs between Pim-1 and c-Myc. This synergism is observed with bitransgenic mice overexpressing c-Myc and Pim-1 in lymphoid tissue with the result that such mice die in utero of pre-Bcell lymphoma (Moroy et al., 1991) .
c-Myc is a basic-helix-loop-helix/leucine zipper transcription factor that is very important in cell growth and differentiation (Cowling and Cole, 2006) . It was shown to promote cell-cycle entry at G 1 /S (Amati et al., 1998) . It can activate many growth-promoting genes via binding to the conserved E-box (CACGTG) through dimerization with its binding partner, Max (Hurlin and Huang, 2006) . c-Myc can also negatively regulate other important genes such as p21 and p27 (Wanzel et al., 2003) . Normally, c-Myc protein has a half-life of less than 20 min (Yeh et al., 2004) . Precise regulation of c-Myc is extremely important for maintaining normal cell growth and function whereas deregulated c-Myc is observed in most of human cancers (Vita and Henriksson, 2006) . Two phosphorylation sites at the N terminus, Thr58 and Ser62, are important in regulating the levels of c-Myc during cell-cycle progression (Sears et al., 2000) . Phosphorylation on Thr58 destabilizes c-Myc whereas phosphorylation on Ser62 stabilizes it. In many tumor cells, deregulation in the phosphorylation status of these two sites in c-Myc has been observed (Malempati et al., 2006) . Mutations at these two sites in Burkitt's lymphoma such as T58A can significantly influence the stability and transforming activity of c-Myc both in vivo and in vitro (Dang et al., 2005) .
We now show that Pim kinases can phosphorylate c-Myc protein in vitro and increase its stability. In tumor cell lines examined that have high expression of both c-Myc and Pim-1 or Pim-2 kinase, knockdown of Pim dramatically decreases the endogenous c-Myc levels and correlates with a decrease in the growth rate of these cells. On the other hand, by stabilizing c-Myc, Pim-1/Pim-2 promotes cell transformation. We propose that the stabilization effect exerted on c-Myc by the Pim kinases might partly explain the strong synergism observed between these two proto-oncogenes.
Results
The Pim kinases phosphorylate c-Myc in vitro It was discovered years ago that overexpression of either Pim-1 or Pim-2 protein kinase and c-Myc in lymphoid organs can synergize in vivo to rapidly induce lymphomas (van Lohuizen et al., 1989; Allen et al., 1997) . Nonetheless, the detailed mechanism for the oncogenic transformation has not been fully elucidated. Therefore, we were interested to determine whether the Pim kinases and c-Myc have some direct interaction. One of the first things we wanted to know was whether c-Myc might be a possible substrate for the Pim kinases, so we performed an in-vitro kinase assay with the purified glutathione S-transferase (GST)-c-Myc protein. As shown in Figure 1a , Pim-2 kinase can efficiently phosphorylate recombinant GST-c-Myc protein in vitro and Pim-1 does also, albeit with a somewhat lower efficiency.
On the basis of consensus sequence of Pim-1 as shown in Figure 1b (Friedmann et al., 1992) , we predicted that there might be four potential phosphorylation sites in the primary sequence of c-Myc (Figure 1b) . Synthesized peptides were utilized to run an in-vitro kinase assay by recombinant Pim kinase. We used the p21 peptide, RKRRQTSM, as a positive control. The incorporation of 32 P by Pim-2 in the different peptide substrates is illustrated in Figure 1c . Peptide I is clearly the most efficiently phosphorylated substrate by Pim-2 kinase. The sequence of this peptide is AKRAKLDSGR. The phosphorylated site is Ser329 and can be phosphorylated by Pim-2 kinase with a very high efficiency. Although Pim-1 also phosphorylates peptide I, we observed lower phosphorylation efficiency as shown in Figure 1d . A sequence alignment of c-Myc among different species reveals that Ser329 is a conserved residue as shown in Figure 1e . In contrast to the previously identified phosphorylation consensus sequence of Pim-1, which needs position -3 to be a conserved Arg as shown in Figure 1b , Pim-2 seems to have a different preference (Peng et al., 2007) . This preference difference between Pim-1 and Pim-2 toward substrates has been observed previously (Macdonald et al., 2006) .
To test whether there are other potential phosphorylation sites, we carried out site-directed mutagenesis to mutate this Ser329 into alanine in c-Myc. As shown in Figure 1f , mutation of Ser329 into Ala causes the efficiency of phosphorylation in GST-c-Myc by Pim-2 kinase to be decreased 60%. This suggests that Ser329 in c-Myc appears to be a major phosphorylation site by Pim-2 kinase. However, mutation of Ser329 into Ala only decreases the phosphorylation efficiency 30% for Pim-1 kinase. This suggests that Ser329 in c-Myc might not be the only phosphorylation site for Pim-1 kinase.
Pim kinase and c-Myc protein associate with each other in vivo To further confirm the direct interaction between c-Myc and Pim kinase, we performed a co-immunoprecipitation analysis as shown in Figure 2 . Overexpressed Pim-1 protein co-precipitated with overexpressed c-Myc as shown in Figure 2a . We also found that Pim-2 kinase interacts with c-Myc as shown in Figure 2b . In addition, we found that endogenous Pim-1 and c-Myc associate with each other as shown in Figure 2c . This is consistent with an observation found in a recent study demonstrating an association between endogenous c-Myc and Pim-1 under growth factor stimulation (Zippo et al., 2007) . It was not possible to demonstrate endogenous Pim-2 association with c-Myc because the levels of endogenous Pim-2 are too low for detection.
The Pim kinases increase c-Myc protein levels We found that Pim kinases cause an increase in the levels of c-Myc in intact cells. As shown in Figure 3a , both Pim kinases (wild type, WT) cause the steady-state level of c-Myc protein to be increased to the same extend as compared to the kinase-dead (KD) Pim kinases. This effect was not only observed in HCT116 cells, but also in a wide variety of cell lines we studied including Cos-7, H1299, HEK293 as well as NIH3T3 cells (Supplementary Figure S1 ). However, we noticed that co-transfecting equal amounts of KD and WT Pim-2 did not result in equal amounts of Pim-2 protein at the time of harvest. In Supplementary Figure S2A , we show that this is because KD Pim-2 is not as stable as WT Pim-2. In addition, we show in Supplementary Figure S2B that even if one brings up the amount of KD Pim-2 in cells to be equal to that of WT Pim-2, c-Myc levels are not increased. Because others have found that decreased phosphorylation on c-Myc Thr58 or increased phosphorylation on c-Myc Ser62 usually correlates with increased stability of c-Myc (Yeh et al., 2004) , we also wanted to determine if Pim kinase overexpression would cause a decrease in c-Myc Thr58 phosphorylation or an increase in Ser62 phosphorylation. As detected by two phospho-specific antibodies, one that recognizes antipT58-c-Myc (under our experimental conditions-see Materials and methods) and one that recognizes anti-pS62-c-Myc, we found that both Pim-1 and Pim-2 kinases appear to mediate a decrease in Thr58 phosphorylation while increasing Ser62 phosphorylation. As shown by quantitation in Figure 3b , we found that the regulation of phosphorylation on Thr58 and Ser62 as a result of increased Pim-1 kinase expression appears to be more dramatic as compared to that mediated by Pim-2 kinase. This indicates that mechanisms other than influences on c-Myc Thr58 and Ser62 phosphorylation must also contribute to the elevation in c-Myc protein levels when Pim kinase, especially Pim-2 kinase, is overexpressed. Therefore, to determine whether phosphorylation on c-Myc Ser329 might have a direct impact on influencing the steady-state levels of c-Myc, we mutated c-Myc Ser329 into Asp to mimic the phosphorylation state. As shown in Figure 3c , we found that c-Myc (S329D) has a higher steady-state level as compared to the WT c-Myc and the S329A mutant of c-Myc. To determine the contribution of c-Myc Ser329 phosphorylation to increased levels of c-Myc, we co-transfected c-Myc Ser329 mutants together with Pim-1 or Pim-2. As shown in Figure 3c , mutation of c-Myc Ser329 into alanine significantly decreases the steady-state levels of c-Myc when co-transfecting Pim-2, providing evidence that c-Myc Ser329 is an important residue for Pim-2 in stabilizing c-Myc, likely through direct phosphorylation. In contrast, the level of S329A mutant of c-Myc is slightly decreased as compared to WT c-Myc when co-transfecting Pim-1 kinase. This is consistent with the less efficient phosphorylation of c-Myc S329 by Pim-1 kinase. R 
Pim-2 kinase stabilizes c-Myc by phosphorylating Ser329
To determine if the higher steady-state level of c-Myc during Pim-2 kinase overexpression was due to the slower turnover rate in vivo of c-Myc, a half-life assay with cycloheximide was carried out to examine c-Myc stability (Figure 4a ). We found that the presence of WT Pim-2 promoted the stabilization of c-Myc protein. As predicted, S329D mutant of c-Myc exhibited a slower degradation rate as compared to WT c-Myc. From the comparison of the degradation rates between c-Myc (S329D) and c-Myc when WT Pim-2 is overexpressed, we found that c-Myc is more stable in the presence of WT Pim-2 than the c-Myc S329D mutant alone (Figure 4a ). When c-Myc Ser329 was mutated into alanine, Pim-2 kinase does not stabilize this mutant c-Myc as much as WT c-Myc as shown in Figure 4b . This further suggests that Ser329 is a major phosphorylation site that contributes to the stabilization of c-Myc by Pim-2 kinase in vivo. On the other hand, the stabilization of c-Myc Ser329A mutant by Pim-1 kinase appears to be slightly less efficient as compared to that of WT c-Myc (Figure 4b ). This suggests that phosphorylation on c-Myc Ser329 is only partly responsible to the stabilization of c-Myc when Pim-1 kinase is overexpressed.
c-Myc protein has a fast turnover rate in vivo with a half-life of around 10-20 min (Yeh et al., 2004) . To confirm the previous result and test the actual half-life of c-Myc stabilized by the Pim kinase, we utilized the method of pulse chase with 35 S as shown in Figure 4c . We found that Pim-1 kinase dramatically extends the half-life of c-Myc from 30 to 90 min. Our data also show that S329D mutant of c-Myc has a half-life longer than exogenous WT c-Myc, but not as long as the c-Myc when WT Pim kinases have been co-overexpressed. This further suggests that phosphorylation on Ser329 is a contributing factor to stabilize c-Myc in the presence of Pim kinases.
Endogenous c-Myc levels can be modulated by Pim-1 and Pim-2 kinases To determine whether Pim-1 kinase could influence c-Myc endogenously, we knocked down Pim-1 with Pim-1 siRNA in H1299 and K562 cells as shown in Figure 5a . Concomitantly, we found that c-Myc expression was also dramatically decreased. We also found that by knocking down Pim-2 by siRNA, that like Pim-1 knockdown, endogenous c-Myc levels were also decreased in both H1299 and DU145 cells (Figure 5b ). These results are consistent with the Pim overexpression studies and indicate that the Pim kinases are capable of influencing c-Myc levels in cells. As it is widely known that c-Myc is important in cell proliferation and cellcycle progression, we predicted that the decrease in c-Myc levels could have a negative influence on tumor cell growth. Therefore, we compared the proliferation of K562 cells either transduced with vector only or with Pim-1 siRNA. That is, we compared the growth curves in liquid media (as shown in Figure 5c ) and the ability of cells to grow in soft agar (as shown in Figure 5d ) for both the control and Pim-1 knockdown cells. We found that knockdown of Pim-1 protein slowed down proliferation of K562 cells as expected in both liquid culture and in soft agar. A dramatic difference in growth rates was observed in H1299 Pim-1 knockdown cells as shown in our previous study (Zhang et al., 2007) . Notably, our data are in agreement with results from Chen et al. (2005) who showed that the levels of endogenous c-Myc were elevated when PC3 cells stably expressing Pim-1 kinase have a shorter doubling time and proliferate faster.
Pim kinase modulates the transcriptional activity of c-Myc To examine whether the transcriptional activity of c-Myc can be influenced by Pim-1 kinase, we performed quantitative reverse transcription (RT)-PCR to analyse the mRNA levels of downstream effectors regulated by c-Myc in both the control and Pim-1 knockdown cells. Sequences of primers are shown in Table 1 . Changes in mRNA levels for these genes are illustrated in Figure 6a control cells, although no change in mRNA levels of c-Myc was observed, suggesting that Pim-1 influences on c-Myc protein levels do not occur at the transcriptional level. As expected, we found that the c-Myc targets, E2F2 and nucleolin, are downregulated, indicating that c-Myc transcriptional activity is decreased when c-Myc protein level is decreased in the Pim-1 knockdown cells. We also found that overexpression of Pim kinases enhances the transcriptional activity of c-Myc. This is demonstrated in vivo with a luciferase assay by cotransfecting the c-Myc plasmid and the pM4min-luciferase reporter that contains four E-boxes into H1299 cells. As shown in Figure 6b , exogenous WT Pim-1 or Pim-2 kinase enhances the transcriptional activity of overexpressed c-Myc as compared to the KD Pim-1 or Pim-2. In addition, overexpression of WT Pim kinase results in a slight increase in the endogenous c-Myc transactivation activity, the overexpression of KD Pim-1/Pim-2 decreases endogenous c-Myc activity twofold. Furthermore, S329D mutant of c-Myc is shown to be more effective in activating the transcription through binding to the E-box as shown in Figure 6c . Mutation of c-Myc Ser329 into alanine significantly decreases the transcriptional activity of c-Myc as compared to WT c-Myc in the presence of WT Pim-2, but only slightly decreases c-Myc transcriptional activity in the presence of Pim-1. These data again provide strong evidence that phosphorylation of c-Myc Ser329 by Pim-2 is important in the stabilization of c-Myc than Pim-1 and this is reflected by a decrease in transcriptional activity when this residue is not available for phosphorylation.
Pim kinases enhance the transforming activity of c-Myc
Pim kinases have been found to synergize with c-Myc to induce lymphoma in vivo (Moroy et al., 1991; van Lohuizen et al., 1991; Allen et al., 1997) . Our results suggest a molecular mechanism whereby stabilizing c-Myc, Pim kinases can enhance the oncogenic transforming properties of c-Myc. To test this hypothesis, we used the soft agar assay to examine whether stabilized c-Myc has a direct effect on enhancing its transforming activity. As shown in Figure 7a , c-Myc, by itself, is able to transform NIH3T3 cells to grow in soft agar, but forming only a few small colonies. However, when cells were transduced with c-Myc and either Pim-1 or Pim-2 retroviral vectors, the transformed cells grew vigorously in soft agar as demonstrated by more and larger colonies. Importantly, the phosphomimic mutant of S-autoradiograph is shown; right, phosphorimaging was used to quantitate the signals and a graph generated by Sigma plot was used to compare the half-life of c-Myc.
Pim kinases stabilize c-Myc
Y Zhang et al c-Myc, S329D, exhibited more potency in transforming the NIH3T3 cells to grow in the soft agar plates as compared with WT c-Myc. When Ser329 was mutated to alanine, fewer colonies grew in the soft agar plates than the WT c-Myc when coexpressing Pim-2 kinase. The numbers of colonies are compared in Figure 7b to underscore the marked variation in the numbers of colonies derived from the different treatments. Again this data support our previous finding that both Pim kinases, by stabilizing c-Myc, enhance the oncogenic transforming activity of c-Myc, although as underscored in Figure 7b , the mechanisms for stabilization by the two kinases via phosphorylation are different.
Discussion
In the current report, we demonstrate a novel mechanism that explains in part the potent synergism between overexpressed Pim-1/Pim-2 and c-Myc in inducing tumor formation. We found that both Pim-1 and Pim-2 kinases stabilize c-Myc in vivo, and we have identified a likely mechanism for this stabilization effect, which is through direct interaction with and phosphorylation of c-Myc. In comparing the two kinases, in vitro Pim-2 phosphorylates c-Myc efficiently, although Pim-1 is somewhat less efficient. Despite this difference of phosphorylation efficiency that we observe in vitro, we found that both the kinases are able to stabilize c-Myc to the same extent in vivo. We also identified a new phosphorylation site, Ser329, which contributes to the stabilization of c-Myc as a result of phosphorylation especially by Pim-2 kinase. This site is neither located in the c-Myc N-terminal transactivation domain nor located in the C-terminal Max interacting domain; rather it is located in the central region and downstream of a nuclear localization signal. This suggests that phosphorylation on this site should not disrupt Maxbinding or DNA-binding activity. The phosphomimic mutant of c-Myc (S329D) has a much longer half-life as compared to WT c-Myc, which suggests that phosphorylation on Ser329 is an important contributing factor in regulating c-Myc stability in the presence of the Pim kinases. However, our results certainly do not fully exclude the possibility that the Pim kinases influence c-Myc protein stability by phosphorylating other sites in addition to Ser329. 
Pim kinases stabilize c-Myc Y Zhang et al Thr58 and Ser62 are important residues whose phosphorylation status controls c-Myc protein stability (Sears et al., 2000; Yeh et al., 2004; Malempati et al., 2006) . Recently, it was reported that Kaposi's sarcoma herpesvirus latency-associated nuclear antigen stabilizes c-Myc by significantly underphosphorylating c-Myc Thr58 (Bubman et al., 2007; Liu et al., 2007) . Elevated levels of c-Myc in Pim-1/Pim-2 overexpressing cell lines were observed previously and it was suggested that this is due to influence of the Pim kinases on phosphorylation of T58 and S62 in c-Myc through decreasing protein phosphatase 2A activity (Chen et al., 2005) . Our results show that Pim-1 and Pim-2 have different influences on regulating c-Myc Thr58 and Ser62 phosphorylation. Pim-1 kinase is more effective in mediating downregulation of Thr58 phosphorylation while increasing Ser62 phosphorylation than Pim-2 kinase. However, Pim-2 is more efficient in direct phosphorylation of c-Myc Ser329 that stabilizes c-Myc. These could explain the mechanism for the observation that Pim-1 and Pim-2 are able to stabilize c-Myc almost to the same extent. Notably, Pim-1 kinase might also modulate the activity of c-Myc via the influences on c-Myc T58 and S62 phosphorylation.
Pim-1 kinase and c-Myc are both found to be highly expressed in certain tumors (Cuypers et al., 1984; de Both et al., 1989; Breuer et al., 1991; Ellwood-Yen et al., 2003) . Coactivation of c-Myc and Pim-1 kinase is frequently observed in Moloney leukemia virus-induced T-cell lymphoma (Selten et al., 1985) . In addition, Pim-1 has also been identified to be a common cooperating partner in transgenic mice that overexpress c-Myc in specific tissues such as prostate and lymphoid (van Lohuizen et al., 1991; van der Lugt et al., 1995; EllwoodYen et al., 2003) . Experiments utilizing RNA interference in tumor cell lines such as K562 and H1299 cells show that when endogenous Pim-1 protein is knocked down, c-Myc steady-state levels are also greatly decreased. However, the mRNA levels of c-Myc as detected by quantitative RT-PCR were not found to be reduced. This suggests that Pim-1's influence on the stabilization of c-Myc protein does not involve transcriptional regulation. The correlation between Pim-1 kinase and c-Myc expression was also manifested by a decrease in the transcriptional activity of c-Myc in Pim-1 knockdown cells. In addition, a marked reduction in the proliferation and growth of these Pim-1 knockdown cells was also observed. These results suggest that high expression of the Pim kinases and c-Myc in tumor cells is relevant, and stabilization of c-Myc by the Pim kinases is probably one of the mechanisms that can explain the synergism between c-Myc and Pim kinases in tumorigenesis. 
pM4min-luciferase assay * * ** ** fold changes In addition, our soft agar analysis reveals that this stable form of c-Myc (S329D) is more potent than WT c-Myc in transforming NIH3T3 cells in vivo. We speculate that this is due to its slower turnover rate as c-Myc protein levels are tightly controlled during normal cell cycle (Amati et al., 1998) . A subtle change during the process could deregulate c-Myc levels that could lead to human malignancies (Pelengaris et al., 2002) . Importantly, our findings demonstrate that aberrant overexpression of the Pim kinases leads to stabilization of c-Myc protein, and this subsequently increases the transforming potential of c-Myc.
Materials and methods

Materials and antibodies
The plasmids pBK/CMV-Pim-1 (WT and KD) were used as described previously (Zhang et al., 2007) . Mouse Pim-2 (cDNA for WT and KD Pim-2 (K61A) were kindly provided by Dr Michael Lilly, Loma Linda University) was PCRamplified to add a FLAG tag at C terminus and inserted into pBK/CMV vector at HindIII/XbaI site. They were also PCRamplified to add a 6XHis at C terminus and inserted into pET30a at NdeI/KpnI site. Mouse c-Myc cDNA was subcloned in-frame into pGEX-2T at BamHI/EcoRI site. PCR-based site-directed mutagenesis was carried out to mutate Ser329 into Ala/Asp in pBK/CMV-c-Myc to generate pBK/CMV-c-Myc (S329A and S329D). A similar method was used to mutate Ser329 into Ala in pGEX-2T to generate pGEX-2T-c-Myc (Ser329A). Human Pim-1 (WT) was subcloned into pLNCX2 at HindIII/NotI site. Mouse Pim-2 (WT) was also subcloned into pLNCX2 at HindIII/NotI site. Similarly, mouse c-Myc (WT) was subcloned into pLNCX2 at HindIII/NotI site. PCR-based site-directed mutagenesis was carried out to mutate Ser329 into Ala/Asp in pLNCX-2-c-Myc to generate pLNCX-2-c-Myc (S329A and S329D). Anti-Pim-1 antibody (1140P) was prepared in our laboratory by immunizing a rabbit with purified recombinant Pim-1 protein.
The following reagents and antibodies were obtained 
